Maintenance Chemotherapy: An Evolving and Increasingly Acceptable Strategy in Cancer Management Maurie Markman ReviewPaper 15 August 2010 Pages: 349 - 351
The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia Amit MahipalMark Weiss Clinical Trial Report 01 September 2010 Pages: 352 - 354
Is Maintenance Rituximab Now Ready for PRIMA-Time? Paul A. Hamlin Clinical Trial Report 02 September 2010 Pages: 355 - 357
Targeted Signal Transduction Therapies in Myeloid Malignancies Emma ScottElizabeth HexnerMartin Carroll ReviewPaper 01 September 2010 Pages: 358 - 365
State-of-the-art Issues in Hodgkin’s Lymphoma Survivorship Shrujal S. BaxiMatthew J. Matasar ReviewPaper 24 August 2010 Pages: 366 - 373
Should Eligible Patients with T-Cell Lymphoma Receive High-Dose Therapy and Autologous Stem Cell Transplant in the Upfront Setting? Carla CasuloSteven Horwitz ReviewPaper 25 August 2010 Pages: 374 - 382
Post-Transplantation Lymphoproliferative Disorders: Diagnosis, Prognosis, and Current Approaches to Therapy Andrew M. EvensRupali RoyLeo I. Gordon ReviewPaper 21 October 2010 Pages: 383 - 394
Maintenance and Consolidation Strategies in Non-Hodgkin’s Lymphoma: A Review of the Data Fredrick B. Hagemeister ReviewPaper 04 September 2010 Pages: 395 - 401
Childhood Rhabdomyosarcoma: New Insight on Biology and Treatment Winston W. HuhStephen X. Skapek ReviewPaper 07 September 2010 Pages: 402 - 410
Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic? Joy M. FulbrightWinston HuhJoya Chandra ReviewPaper 07 September 2010 Pages: 411 - 419